Not available
Quote | Evofem Biosciences Inc. (NASDAQ:EVFM)
Last: | $0.4782 |
---|---|
Change Percent: | -36.49% |
Open: | $0.4401 |
Close: | $0.7529 |
High: | $0.59 |
Low: | $0.43 |
Volume: | 51,997,652 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Evofem Biosciences Inc. (NASDAQ:EVFM)
Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO PR Newswire -- Application allowed with broad method claims that are Orange Book-listable -- -- Once issued, this will be Evofem's fifth patent covering Hormone-Free "In th...
2024-03-27 13:52:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evofem Biosciences (NASDAQ: EVFM ) just reported results for the fourth quarter of 2023. Evofem Biosciences reported earnings per share of -44 cents. The company repor...
Message Board Posts | Evofem Biosciences Inc. (NASDAQ:EVFM)
Subject | By | Source | When |
---|---|---|---|
Is $EVFM planning to up-list to Nasdaq? | dazetrader | investorshub | 05/17/2023 6:13:49 PM |
The gaining last up | ErnieBilco | investorshub | 05/16/2023 5:27:41 PM |
here we go bulls news is here | LowFloatLopes | investorshub | 05/14/2023 7:43:50 AM |
Just gotta know when to buy and sell | LowFloatLopes | investorshub | 05/14/2023 2:32:43 AM |
OTC IS BS man,hope $VIRI does us good | The Night Stalker | investorshub | 05/14/2023 2:31:37 AM |
News, Short Squeeze, Breakout and More Instantly...
Evofem Biosciences Inc. Company Name:
EVFM Stock Symbol:
NASDAQ Market:
Evofem Biosciences Inc. Website:
Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO PR Newswire -- Application allowed with broad method claims that are Orange Book-listable -- -- Once issued, this will be Evofem's fifth patent covering Hormone-Free "In th...
Aditxt (NASDAQ: ADTX) previously entered into a definitive agreement to acquire Evofem Biosciences Inc. (OTCQB: EVFM) , which is believed to represent a compelling opportunity to accelerate Evofem’s growth trajectory, as a subsidiary of Aditxt, into a multi-product women’s health ...